Comment on Scientific production in the era of large language models
对《大语言模型时代的科学产出》的评论AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要围绕处理时间的内生选择、事件研究伪效应及安慰剂检验展开,直接涉及因果推断设计的有效性。
对《大语言模型时代的科学产出》的评论AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Kusumegi et al. (2025) study whether researchers' preprint output rises after adopting large language models (LLMs), dating adoption as the first month in which at least one submitted abstract exceeds an LLM-detection threshold. We show that this treatment-timing rule is mechanically related to output. The probability that at least one paper is flagged in a month is increasing in the number of papers submitted in that month, so detected-adoption months are disproportionately high-output months. An event study centered on first detection can therefore display positive post-event dynamics even when the flagging rule contains no information about true LLM adoption, because the omitted pre-treatment period is selected from months with no prior detection. We demonstrate this in a simulation: with i.i.d. productivity and no causal effect, first-detection timing generates a spurious positive post-treatment path. We also replicate the stacked event study of Kusumegi et al. (2025) and show that three placebo exercises (random paper-level assignment, neutral keyword flags, and a pre-ChatGPT observation window) each produce a similarly positive post-treatment pattern.
We study difference-in-differences designs in which all units are initially untreated and later receive heterogeneous, strictly positive treatment doses. When quasi-untreated units receive doses close to zero, a difference-in-difference estimand using those units as the control group identifies a weighted average treatment effect per unit of treatment, under a parallel-trends assumption. We develop a nonparametric estimator and bias-corrected confidence intervals for this…
伪面板事件研究:可信应用的计量经济学基础
Event studies with panel data are widely used to estimate treatment effects. With repeated cross-sections, future treatment dates are unobserved for untreated individuals. Pseudo-panel event studies impute pre-treatment outcomes of the treated using matched untreated individuals. This paper establishes identification in such designs and characterizes bias when identification conditions fail. I show that the pseudo-panel regression is equivalent to weighted least squares with…
We develop the first empirically implementable selective-inference framework for difference-in-differences with controls selected by pre-treatment fit. We construct confidence intervals for the average treatment effect on the treated (ATT), incorporating that selection and estimating the unknown full covariance from the same observations. Counterexamples establish undercoverage from Roth's fixed-comparison pretest adjustment and direct Gaussian-score application of…
Researchers often report an estimate and confidence interval only if a specification test does not reject - for example, only if a pre-trend test supports a difference-in-differences design. Does this make the reported confidence interval less reliable? We show that when the identifying assumptions hold, the answer is no: conditional on passing the pre-test, the confidence interval may over-cover but cannot under-cover. When the assumptions fail, pre-testing can reduce…
以模型平均替代处理前趋势检验
We study difference-in-differences (DID) estimation of average treatment effects on the treated when the researcher is uncertain about which pre-treatment periods satisfy the parallel trends assumption. Roth (2022) shows that pre-trend testing can induce bias, complementing the statistical literature on post-selection inference. We propose the model averaged difference-in-differences (MADID) estimator, a weighted average of the candidate $2\times2$ DID estimators. The…
利用辅助事件信息进行删失结局的因果推断
Clinical trials with survival endpoints lose information when participants are censored before death is observed. We develop target-preserving estimators that use posttreatment disease history, such as recurrence or progression, to recover information lost to censoring for marginal survival and restricted mean survival effects. The difficulty is that the intermediate event is downstream of treatment: naive adjustment can change the causal estimand, and the useful information…